Patents by Inventor Vladimir Malashkevich

Vladimir Malashkevich has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Inhibitors of HIV membrane fusion
    Patent number: 7960504
    Abstract: Inhibitors of HIV membrane fusion and a method of identifying drugs or agents which inhibit binding of the N-helix coiled-coil and the C helix of HIV gp41 envelope protein.
    Type: Grant
    Filed: November 12, 2004
    Date of Patent: June 14, 2011
    Assignee: Whitehead Institute for Biomedical Research
    Inventors: Debra M. Eckert, David C. Chan, Vladimir Malashkevich, Peter A. Carr, Peter S. Kim
  • Inhibitors of HIV membrane fusion
    Publication number: 20050221294
    Abstract: Inhibitors of HIV membrane fusion and a method of identifying drugs or agents which inhibit binding of the N-helix coiled-coil and the C helix of HIV gp41 envelope protein.
    Type: Application
    Filed: November 12, 2004
    Publication date: October 6, 2005
    Applicant: Whitehead Institute for Biomedical Research
    Inventors: Debra Eckert, David Chan, Vladimir Malashkevich, Peter Carr, Peter Kim
  • Inhibitors of HIV membrane fusion
    Patent number: 6841657
    Abstract: Inhibitors of HIV membrane fusion and a method of identifying drugs or agents which inhibit binding of the N-helix coiled-coil and the C helix of HIV gp41 envelope protein.
    Type: Grant
    Filed: December 21, 2000
    Date of Patent: January 11, 2005
    Assignee: Whitehead Institute for Biomedical Research
    Inventors: Debra M. Eckert, David C. Chan, Vladimir Malashkevich, Peter A. Carr, Peter S. Kim
  • Inhibitors of HIV membrane fusion
    Publication number: 20020077284
    Abstract: Inhibitors of HIV membrane fusion and a method of identifying drugs or agents which inhibit binding of the N-helix coiled-coil and the C helix of HIV gp41 envelope protein.
    Type: Application
    Filed: December 21, 2000
    Publication date: June 20, 2002
    Applicant: Whitehead Institute For Biomedical Research
    Inventors: Debra M. Eckert, David C. Chan, Vladimir Malashkevich, Peter A. Carr, Peter S. Kim
  • Human respiratory syncytial virus
    Publication number: 20010043931
    Abstract: A method of identifying a drug that inhibits the RSV membrane fusion machinery, such as the HRSV membrane fusion machinery; drugs that bind the N-helix coiled-coil of HRSV, particularly the N-helix coiled-coil pocket, and, thus, inhibit HRSV infection of cells, such as human cells; methods of inhibiting (partially or totally) HRSV infection of an individual; anitbodies that bind to the N-helix coiled-coil region of HRSV F1; and pharmaceutical compositions comprising HRSV infection neutralizing antibodies.
    Type: Application
    Filed: December 5, 2000
    Publication date: November 22, 2001
    Applicant: Whitehead Institute for Biomedical Research
    Inventors: Xun Zhao, Mona Singh, Vladimir Malashkevich, Peter S. Kim